I-

i-mobile Co.,Ltd.

Operates one of Japan's largest ad networks and a 'Furusato Nozei' tax donation website.

6535 | T

Overview

Corporate Details

ISIN(s):
JP3105210003
LEI:
Country:
Japan
Address:
渋谷区桜丘町22−14 N.E.S.ビルN棟2階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

i-mobile Co., Ltd. is a technology company with two primary business segments: Online Advertising and Consumer Services. The company operates one of Japan's largest domestic ad networks, providing a comprehensive platform for advertisers to promote products and for publishers to monetize content across PCs, smartphones, and applications. Its advertising services include performance-based solutions and affiliate marketing programs. The Consumer Service segment is centered on its 'Furusato Nozei' (hometown tax payment) support website, which simplifies the tax donation process for users. The company has also expanded its operations into the green energy sector.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-23 05:02
Registration Form
確認書
Japanese 8.7 KB
2025-10-23 05:00
Annual Report
有価証券報告書-第18期(2024/08/01-2025/07/31)
Japanese 1.3 MB
2025-08-15 05:49
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.0 KB
2025-07-01 09:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.7 KB
2025-04-02 05:01
Regulatory News Service
臨時報告書
Japanese 19.5 KB
2025-03-14 07:04
Interim Report
確認書
Japanese 8.7 KB
2025-03-14 07:03
Interim Report
半期報告書-第18期(2024/08/01-2025/07/31)
Japanese 216.7 KB
2024-10-28 07:16
Post-Annual General Meeting Information
臨時報告書
Japanese 23.3 KB
2024-10-28 07:15
Registration Form
確認書
Japanese 8.9 KB
2024-10-28 07:15
Governance Information
内部統制報告書-第17期(2023/08/01-2024/07/31)
Japanese 23.5 KB
2024-10-28 07:14
Annual Report
有価証券報告書-第17期(2023/08/01-2024/07/31)
Japanese 1.3 MB
2024-06-12 08:03
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-06-12 08:01
Quarterly Report
四半期報告書-第17期第3四半期(2024/02/01-2024/04/30)
Japanese 180.2 KB
2024-03-13 07:03
Quarterly Report
四半期報告書-第17期第2四半期(2023/11/01-2024/01/31)
Japanese 216.3 KB
2024-03-13 07:03
Report Publication Announcement
確認書
Japanese 8.7 KB

Automate Your Workflow. Get a real-time feed of all i-mobile Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for i-mobile Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for i-mobile Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Mendus Logo
Developing immunotherapies using dendritic cells to prevent cancer recurrence and improve survival.
Sweden IMMU
Develops AI-driven, glasses-free 3D holographic displays for the defense sector.
United States of America N/A
MicroAd,Inc. Logo
Data-driven marketing tech providing DSP and SSP solutions for digital advertising.
Japan 9553
Microwave Chemical Co., Ltd. Logo
Innovating chemical and metal processing with an eco-friendly microwave platform.
Japan 9227
A think tank providing research, consulting, and ICT solutions to public & private sectors.
Japan 3636
Modalis Therapeutics Corporation Logo
Develops epigenome editing therapies for genetic muscular, heart, and CNS disorders.
Japan 4883
Model Solution Co., Ltd. Logo
One-stop prototyping & low-volume production for IT, electronics, and medical hardware.
South Korea 417970
Modus Therapeutics Holding AB Logo
Developing sevuparin, a polysaccharide for sepsis, septic shock, and chronic inflammation.
Sweden MODTX
Molecure S.A. Logo
Develops first-in-class small molecule drugs for oncology and inflammatory/fibrotic diseases.
Poland MOC
Mural Oncology PLC Logo
Clinical-stage company developing cytokine immunotherapies for hard-to-treat solid tumors.
Ireland MURA

Talk to a Data Expert

Have a question? We'll get back to you promptly.